CVS Health's turnaround efforts in focus amid record-high medical costs
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
ANRO stock touches 52-week low at $3.23 amid market challenges
In a turbulent market environment, Alto Neuroscience's stock (ANRO) has recorded a new 52-week low, dipping to $3.23, marking a stark contrast to its 52-week high of $18.35. According to InvestingPro ...